@article{JTD24092,
author = {Qinghua Zhou and Jingsi Dong and Jie He and Deruo Liu and David H. Tian and Shugeng Gao and Shanqing Li and Lunxu Liu and Jianxing He and Yunchao Huang and Shidong Xu and Weimin Mao and Qunyou Tan and Chun Chen and Xiaofei Li and Zhu Zhang and Gening Jiang and Lin Xu and Lanjun Zhang and Jianhua Fu and Hui Li and Qun Wang and Lijie Tan and Danqing Li and Qinghua Zhou and Xiangning Fu and Zhongmin Jiang and Haiquan Chen and Wentao Fang and Xun Zhang and Yin Li and Ti Tong and Zhentao Yu and Yongyu Liu and Xiuyi Zhi and Tiansheng Yan and Xingyi Zhang and Roberto F. Casal and Eugenio Pompeo and Angelo Carretta and Marc Riquet and Ottavio Rena and Pierre-Emmanuel Falcoz and Hisashi Saji and Ali Zamir Khan and Jose Luis Danguilan and Diego Gonzalez-Rivas and Nicolas Guibert and Chengchu Zhu and Jianfei Shen},
title = {The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {9},
year = {2018},
keywords = {},
abstract = {In 1883, Leyden successfully performed percutaneous transthoracic needle biopsy (PTNB) of the lung in three patients with pneumonia according the records (1); three years later, Menetrier was the first recorded to employ this technique for the diagnosis of lung cancer (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24092}
}